Logo image of CNCK

COINCHECK GROUP NV (CNCK) Stock Fundamental Analysis

USA - NASDAQ:CNCK - NL0015002BV9 - Common Stock

5.08 USD
+0.43 (+9.25%)
Last: 10/6/2025, 9:33:10 PM
4.66 USD
-0.42 (-8.27%)
After Hours: 10/6/2025, 9:33:10 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CNCK. CNCK was compared to 238 industry peers in the Capital Markets industry. While CNCK seems to be doing ok healthwise, there are quite some concerns on its profitability. CNCK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CNCK has reported negative net income.
CNCK had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CNCK reported negative net income in multiple years.
CNCK had a negative operating cash flow in each of the past 5 years.
CNCK Yearly Net Income VS EBIT VS OCF VS FCFCNCK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -13.34%, CNCK is doing worse than 85.71% of the companies in the same industry.
The Return On Equity of CNCK (-163.20%) is worse than 90.76% of its industry peers.
Industry RankSector Rank
ROA -13.34%
ROE -163.2%
ROIC N/A
ROA(3y)-0.08%
ROA(5y)-0.08%
ROE(3y)-37.84%
ROE(5y)-22.73%
ROIC(3y)N/A
ROIC(5y)N/A
CNCK Yearly ROA, ROE, ROICCNCK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

With a Gross Margin value of 3.33%, CNCK is not doing good in the industry: 71.01% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for CNCK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNCK Yearly Profit, Operating, Gross MarginsCNCK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

6

2. Health

2.1 Basic Checks

CNCK has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CNCK has a worse debt to assets ratio.
CNCK Yearly Shares OutstandingCNCK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CNCK Yearly Total Debt VS Total AssetsCNCK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

An Altman-Z score of 3.67 indicates that CNCK is not in any danger for bankruptcy at the moment.
CNCK has a Altman-Z score of 3.67. This is in the better half of the industry: CNCK outperforms 79.41% of its industry peers.
There is no outstanding debt for CNCK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.67
ROIC/WACCN/A
WACCN/A
CNCK Yearly LT Debt VS Equity VS FCFCNCK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B 10B

2.3 Liquidity

CNCK has a Current Ratio of 1.06. This is a normal value and indicates that CNCK is financially healthy and should not expect problems in meeting its short term obligations.
CNCK has a Current ratio of 1.06. This is comparable to the rest of the industry: CNCK outperforms 44.54% of its industry peers.
A Quick Ratio of 1.06 indicates that CNCK should not have too much problems paying its short term obligations.
The Quick ratio of CNCK (1.06) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
CNCK Yearly Current Assets VS Current LiabilitesCNCK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CNCK have decreased strongly by -3805.97% in the last year.
The Revenue has grown by 420.62% in the past year. This is a very strong growth!
EPS 1Y (TTM)-3805.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-415.11%
Revenue 1Y (TTM)420.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.23%

3.2 Future

The Earnings Per Share is expected to grow by 45.91% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.59% on average over the next years. This is quite good.
EPS Next Y97.78%
EPS Next 2Y45.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.59%
Revenue Next 2Y17.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CNCK Yearly Revenue VS EstimatesCNCK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 100B 200B 300B
CNCK Yearly EPS VS EstimatesCNCK Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 0 0.02 0.04 0.06 0.08

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNCK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CNCK is valuated quite expensively with a Price/Forward Earnings ratio of 7788.78.
Based on the Price/Forward Earnings ratio, CNCK is valued a bit more expensive than 74.79% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.36, CNCK is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 7788.78
CNCK Price Earnings VS Forward Price EarningsCNCK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 2K 4K 6K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNCK Per share dataCNCK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNCK does not grow enough to justify the current Price/Earnings ratio.
CNCK's earnings are expected to grow with 45.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.91%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNCK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COINCHECK GROUP NV

NASDAQ:CNCK (10/6/2025, 9:33:10 PM)

After market: 4.66 -0.42 (-8.27%)

5.08

+0.43 (+9.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)N/A N/A
Inst Owners1.54%
Inst Owner Change0%
Ins Owners7.42%
Ins Owner Change0%
Market Cap664.51M
Analysts45.71
Price Target6.12 (20.47%)
Short Float %1.05%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)49.8%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-159.46%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)13.49%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.29%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7788.78
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 9.89
P/tB 13.31
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)0
Fwd EY0.01%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS20.34
BVpS0.51
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.34%
ROE -163.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.33%
FCFM N/A
ROA(3y)-0.08%
ROA(5y)-0.08%
ROE(3y)-37.84%
ROE(5y)-22.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover3.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 106.64%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 3.67
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)93.96%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3805.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-415.11%
EPS Next Y97.78%
EPS Next 2Y45.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)420.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.23%
Revenue Next Year6.59%
Revenue Next 2Y17.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-488.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year374.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-448733%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-322900%
OCF growth 3YN/A
OCF growth 5YN/A